Massey Cancer Center
P.O. Box 980234
Richmond VA 23298-0234
Mission Statement The mission of Massey Cancer Center is to serve the Commonwealth as an internationally recognized comprehensive center of excellence in cancer research, prevention/control and patient care, education.  Our guiding principles are to make important discoveries about cancer, and to translate these discoveries rapidly into better detection, prevention, treatment and control of cancer to enhance the quality of life of all individuals affected by cancer. 
CEO/Executive Director Gordon D. Ginder MD
Board Chair Pamela Kiecker Royall
Board Chair Company Affiliation Royall & Company
Contact Information
Address P.O. Box 980234
Richmond, VA 232980234
Telephone 804 828-0450
Fax 804 824-0452
History and Background
Year of Incorporation 1960
Financial Summary
Revenue vs Expense Bar Graph - All Years
Expense Breakdown Bar Chart - All Years
Projected Revenue $30,938,921.00
Projected Expenses $1,723,379.00
Additional Documents
Form 990 - MCV Foundation2013View
Audited Financial Statements - MCV Foundation2013View
Form 990 - MCV Foundation2012View
Audited Financial Statements - MCV Foundation2012View
Form 990 - MCV Foundation2011View
Audited Financial Statements - MCV Foundation2011View
Mission The mission of Massey Cancer Center is to serve the Commonwealth as an internationally recognized comprehensive center of excellence in cancer research, prevention/control and patient care, education.  Our guiding principles are to make important discoveries about cancer, and to translate these discoveries rapidly into better detection, prevention, treatment and control of cancer to enhance the quality of life of all individuals affected by cancer. 
In FY2010, VCU Massey Cancer Center was successful in:
  • Attracting and retaining top-caliber physician-scientists and researchers from across the country.
  • Ensuring that patient care is backed by the most advanced research, by offering 210 clinical trials, including 53 new therapeutic trials.
  • Opening five new investigator-initiated Phase I clinical trials, bringing Massey's lab research to the patient.
  • Establishing three affliliate partnerships in Lynchburg, Fredericksburg and on Virginia's peninsula, providing access to quality patient care and clinical trials to a greater portion of the Commonwealth's population. 
  • Increasing peer-reviewed sponsored research projects by 14% for a total of $38,570,472 in funding.
  • Raising nearly $6 million in private funds to support Massey's research enterprise.
Massey's FY2011 goals include:
  • Opening six new Phase I or II clinical trials
  • Increasing rate of participation in clinical trials to 15%
  • Continue expanding statewide clinical trials network
  • Raise $10 million in private funds to support Massey's research enterprise.
Massey's most pressing needs all support the primary goal of obtaining the National Cancer Institute's "Comprehensive" designation:
  • Expand clinical trials network in order to increase patient participation to 15%.
  • Increase funding for five core research programs to ensure that promising ideas can be explored to their fullest.
  • Establish endowed chairmanships to ensure recruitment of top-caliber faculty members
  • Recruit and retain nationally-acclaimed researchers and clinical trials teams
  • Provide technologically advanced research facilities.
1974 - The VCU Board of Visitors established a cancer center on the MCV Campus and a planning grant was received from the National Cancer Institute (NCI).
1975 - The first Cancer Center Support Grant (CCSG) was funded by the NCI, with Walter Lawrence, Jr., M.D., a surgeon and former president of the American Cancer Society, as a prinicpal investigator and director of the cancer center.
1983 - The cancer center was named VCU Massey Cancer Center in honor of a major gift by William and Evan Massey.
1986 - North Hospital (renovated former E.G. Williams Hospital) opened, which today houses VCU Massey Cancer Center's Dalton Oncology Clinic, Radiation Oncology Department, BMT in-patient and out-patient clinics and Thomas Palliative Care Unit.
1987 - The Department of Radiation Oncology was established.
1988 - I. David Goldman, M.D., formerly director of Albert Einstein Cancer Center at Yeshiva University, became director of VCU Massey Cancer Center.
1993 - The Schools of Medicine and Basic Health Sciences merged.
1995 - Francis Macrina, Ph.D., formerly vice president for research at VCU School of Dentistry, became interim director of VCU Massey Cancer Center.
1997 - Gordon Ginder, M.D., former associate director of the University of Minnesota Cancer Center, became director of VCU Massey Cancer Center.
2006 - VCU Massey Cancer Center opened Goodwin Research Laboratory, an 80,000 square foot, state-of-art cancer research facility.
2008 - VCU Medical Center opened the Critical Care Hospital, which includes VCU Massey Cancer Center's in-patient oncology care unit.
Today - Under Dr. Ginder's tenure, VCU Massey Cancer Center has taken on and maintained a trajectory of carefully planned steady growth, substantially building its scientific base while simultaneously sharpening its cancer focus and its dedication to translational research.
CEO Statement
At VCU Massey Cancer Center, our focus is simple... to save and improve more lives.  But our adversary is complex.  We know that the tools we need to relieve suffering caused by cancer are found in additional, more effective research. 

Because of the research and clinical work we do at Massey, lives that would have been lost five years ago are now extended or saved.  But every life we cannot save reminds us to quicken the pace.  We need to explore more well-conceived concepts, more opportunities to collaborate, and more clinical trials to bring powerful new treatments to patients...and we need them now.
Research is the only true hope for saving lives.  Massey has a solid foundation, but we need to broaden and deepen our research operation.  We can do this by attracting and retaining the world's brightest minds in cancer research to build even more dynamic and productive teams.  But we must provide them with the necessary resources, including well-equipped space for these remarkable synergies to happen.  As a result, we will not only develop successful new treatment options for cancer patients here in Virginia, but we will also enhance our role in leading and shaping the national efforts to defeat cancer.
Your support in expanding our research enterprise will allow Massey Cancer Center to become the first National Cancer Institute (NCI)-designated "Comprehensive" Cancer Center in Virginia.  Massey is already among the selected 66 NCI-designated Cancer Centers in the country, but our goal is to obtain this highest distinction.  This added prestige will help us successfully compete for new grant funding and attract the best cancer researchers and physician-scientists. 
More importantly, NCI Comprehensive status will further signify that hope is here in Richmond, Virginia.  Patients and Central Virginia and beyond do not need to travel for care.  They can stay in their own environment, with the encouragement, love and support of their family and friends.
The time is right to invest in research and in Massey.  This year, 15,000 Virginians will die from cancer.  By accelerating the pace of research, we can reduce this number.  Please join us in defeating cancer. 
Areas of Service
Areas Served
VCU Massey Cancer Center is a national leader in cancer research.  Backed by a designation from the National Cancer Institute (NCI), Massey's researchers and physicians collaborate with peers across the country to bring the latest treatments to patients and share knowledge that advances research breakthroughs.
Massey treats patients from across Virginia at the VCU Medical Center, Stony Point, Hanover, McGuire Veterans Affairs Medical Center, and outreach clinics at Rappahannock General Hospital (Kilmarnock) and Southern Regional Memorial Hospital (Emporia).  Three affiliate partnerships have recently been established in Lynchburg, Fredericksburg and on Virginia's peninsula, providing access to quality patient care and clinical trials to a greater portion of the Commonwealth's population. 
Board Chair
Board Chair Pamela Kiecker Royall
Company Affiliation Royall & Company
Term July 2014 to June 2017
Board of Directors
Board Members
Dr. Ralph H.B. Anderson Community Volunteer
Shelley E. Arthur Owner, Shelly Arthur Landscape & Garden Design LLC
Ann H. Austin Community Volunteer
Ms. Mary Davey Bliley Community Volunteer
Roger L. Boeve Former Vice President, Performance Foods
Jean Ann Bolling Community Volunteer
Ms. Joanna A. Brennan Community Volunteer
J. Alfred Broaddus Former Director, Richmond Federal Reserve
Judy S. Brown Community Volunteer
Peter W. Brown Surgeon, Virginia Surgical Associates
Mandy Burnette Greater Richmond Chamber of Commerce
Charles L. Cabell Williams Mullen
Jill Thalhimer Campbell LCSW, Jewish Family Services
Mr. Theodore L. Chandler Jr.Corporate Consultant
Judy T. Clough Community Volunteer
Mr. John R. Congdon Old Dominion Truck Leasing Inc.
Paul W. Croston Partner, KPMG
Mr. Wesley I Crowder Community Volunteer
Julia B. Curtis Independent Scholar
Ms. Erika T. Davis Community Volunteer
Mr. Melvin L. Davis Jr.Community Volunteer
Ms. Lila H. Dickinson Community Volunteer
George P. Emerson President, Emerson Construction Company
Matthew J. Ernst President/CEO, Walnut Grove Holdings, LLC
Ms. Corinne Garland Community Volunteer
Ms. Beatriz Gonzalez Capital Results LLC
Christina Gore Community Volunteer
Ann Parker Gottwald Community Volunteer
L. Michael Gracik Keiter
Mr. Theodore S. Hanson CFO, Apex Systems, Inc.
Terrell Luck Harrigan Community Volunteer
H. Hiter Harris IIIPresident, Harris Williams & Co.
Elizabeth S. Hart Owner, Design Stages, LLC
Karen D. Higgins Ameriprise Financial
C.T. Hill SunTrust Banks, Inc.
Honorable R. Edward Houck Senate of Virginia
Cecilia S. Howell Community Volunteer
Olin V. Hyde Retired President, Sealeze Corporation
Joseph R. Jenkins Community Volunteer
Mr. Mark Johnson Community Volunteer
Stanley Knight Joynes IIIValley Road Vineyards, LC
Martha Browning Krupin Community Volunteer, Richmond, Va. and Los Angeles, Calif.
Linwood A. Lacy Jr.Corporate Entrepreneur
Jarold D. Langley Community Volunteer
Betty Sue Grandis LePage H&H Grandis Properties
James Ludwig Community Volunteer
David A. Lyons Managing Director, Lowe, Brockenbrough & Company
Rebecca C. Massey Community Volunteer
A. Travis Massey Business Development, GPB Scientific LLC
Ms. Patricia Merrill Sr. VP and Deputy General Counsel, Genworth Financial Inc.
James Scott Merritt IIIUniversity of Richmond
Henry R. Miller IVSenior Vice President, RBC Wealth Management
Mr. David J. Mills Community Volunteer
Jacques J. Moore Moore Cadillac
James T. Napier President, Napier Realtors ERA
Julian T. Ottley President, Ottley Properties, Inc.
Ms. Catherine S. Plotkin Community Volunteer
Mrs. Martha Orr Proutt Heritage Wealth Advisors
Teri Carnes Pruitt W.S. Carnes Company
Hon. Anne J. Rhodes Retired
Dr. Pamela Kiecker Royall Royall and Company
Mr. E. Lee Showalter Retired
Lisa Sims Venture Richmond
Susan Sisisky Community Volunteer
Raymond M. Slabaugh IIIRetired, Willis
Vickie M. Snead Community Volunteer
Mr. Levar M. Stoney Secretary of the Commonwealth
Elizabeth H. Thornton Virginia Senate
Judy Harris Turbeville Community Volunteer
Chanda Wallace Community Volunteer
Anne Marie Whittemore Partner, McGuireWoods
Robert G. Whitten Whitten Bros, Inc.
Amy McDaniel Williams Hunton & Williams LLP
Board Demographics - Ethnicity
African American/Black 5
Asian American/Pacific Islander 0
Caucasian 67
Hispanic/Latino 1
Native American/American Indian 0
Board Demographics - Gender
Male 36
Female 37
Board Term Lengths 3
Board Term Limits 2
Written Board Selection Criteria? Yes
Written Conflict of Interest Policy? No
Percentage Making Monetary Contributions 100
Number of Full Board Meetings Annually 4
Other Boards
The tables below contain information about other groups that advise this nonprofit on operations and projects.
Executive Director
Executive Director Gordon D. Ginder MD
Dr. Ginder received his M.D. from Johns Hopkins followed by training in internal medicine at Case Western Reserve University Hospital and training in molecular genetics at the National Institutes of Health. He then completed a fellowship in medical oncology and hematology at the University of Iowa where he was appointed to the faculty and rose to the rank of professor and Associate Director of Hematology/Oncology. In 1990 Dr. Ginder was appointed Director of Medical Oncology and Masonic Professor of Oncology and member of the Institute of Human Genetics at the University o fMinnesota; he was subsequently appointed Associate Director of the University of Minnesota Cancer Center and held those posts until his appointment as Director of the Massey Cancer Center.

               Dr. Ginder’s laboratory research has focused on the regulation of gene expression and the translation of basic gene regulation mechanisms to clinical interventions in cancer and blood diseases. His current laboratory activities center on mechanisms of gene regulation during blood cell differentiation and on the regulation of genes that are critical to immune cell killing of cancer cells. Dr. Ginder has remained active in clinical studies and care of patients with cancer, primarily in the areas of cancers of blood and lymph node cells and bone marrow transplantation. Also, he has been active in the training of basic researchers and clinical specialists in cancer and blood diseases, having directed post doctoral fellow-ship programs at the University of Iowa and University of Minnesota in addition to Virginia Commonwealth University. His research has been continuously supported by the National Institutes of Health and the National Cancer Institute for over 22 years, and he is the recipient of an NIH MERIT award.

               Dr. Ginder has served on numerous review boards for the NIH and the American Cancer Society. Currently, he is serving on the National Scientific Advisory Board for Institutional Research Grants for the American Cancer Society. He is a member of several professional societies including the American Association for Cancer Research, the American Society of Hematology, and the American Society for Clinical Oncology, the American Society of Clinical Investigation, and the American Association of Professors.


Organization has a Fundraising Plan? Yes
Organization has a Strategic Plan? Yes
Years Strategic Plan Considers 5
Date Strategic Plan Adopted Oct 2008
VCU Massey Cancer Center has been designated by the National Cancer Institute since 1974 because of our scientific excellence in cancer research and our vital role in reducing cancer morbidity and mortality.  We are one of only two centers in the state with this designation.

Our scientists conduct lab and clinical research to discover better ways to prevent, diagnose and treat cancer.  Nearly 130 of these researchers are faculty from 22 VCU academic departments.  They collaborate on research in five key programs:

Cancer Cell Signaling - identifying key signaling pathways that contribute to cancer.
Cancer Molecular Genetics - investigating genetic and epigenetic changes that underline the molecular and cellular events contributing to cancer development and progression and using this information to develop new target-based therapies for cancer.

Cancer Prevention and Control - developing basic and applied research programs in behavioral, social and population sciences to create or enhance interventions that reduce cancer risk, incidence, morbidity and mortality, and enhance quality of life.
Developmental Therapeutics - exploring cancer therapeutics, identifying molecular targets, assessing the molecular genetic profiles of tumors and translating these findings into the development of novel therapeutic strategies for the treatment of cancer.
Radiation Biology and Oncology - examining effects of radiation on tumor cells at the molecular level to determine radioresistance and how to optimally deliver radiation to more effectively treat cancer. 
Our patients choose VCU Massey Cancer Center for two key reasons:  the treatment options we provide and the cancer specialists who provide them. 

We offer the clinical services and advanced treatment options that are only available at a National Cancer Institute-designated cancer center like ours.  Massey is one of only two cancer centers in Virginia designated by NCI, and one of only 66 in the United States.
We have hundreds of top cancer specialists serving the needs of our patients.  Massey's clinical and research staff provide a wealth of expertise in cancer diagnosis, treatment, prevention and symptom management.

Access to clinical trials: We also offer patients the newest forms of treatment, which are often only available on a study, or clinical trial, basis.  Through translational research, our core area of research expertise, we translate our latest laboratory breakthroughs into patient care.  Eligible patients may choose to participate in more than 100 clinical trials being offered at any given time. 
Treatment by multidisciplinary process: At VCU Massey Cancer Center, our patients are treated by multidisciplinary teams, which consist of a variety of cancer specialtists across multiple disciplines.  Each team collaborates on every case, ensuring the best possible treatment plan for each individual patient.  The patient is evaluated by a group of oncologists, surgeons, radiologists, nurse practitioners, therapists and others, all of whom meet on a regular basis.
Clinical Research Affiliation Network
In striving to serve all Virginians, VCU Massey Cancer Center is expanding its clinical trial offering statewide to provide more patients access to the latest, cutting-edge cancer therapies, medical devices or prevention methods obtained through clinical trials.  In 2011, our integrated clinical trials network consisted of affiliate partnerships in Lynchburg, Fredericksburg, Danville and Hampton Roads.  This network enables health systems and oncology medical practices throughout the Commonwealth to access Massey's excellence in research and its expertise in developing and managing clinical trials. 

Health Information & Advocacy @ Your Library
HIA@Your Library is an online portal designed to make personal health and medical research easier and more reliable.  Funded by the Tobacco Indemnification and Community Revitalization Commission, the program has been implemented in eleven library systems in the tobacco counties of Virginia.  Residents can use this free website to access better health information or for local resources to help improve their health or the health of others. 
Fiscal Year
Projected Revenue $30,938,921.00
Projected Expenses $1,723,379.00
Form 990s
IRS Letter of Exemption
Detailed Financials
Revenue SourcesHelpThe financial analysis involves a comparison of the IRS Form 990 and the audit report (when available) and revenue sources may not sum to total based on reconciliation differences. Revenue from foundations and corporations may include individual contributions when not itemized separately.
Fiscal Year201420132012
Foundation and
Corporation Contributions
Government Contributions$0$0$0
Individual Contributions$7,735,431$7,710,956$28,144,850
Investment Income, Net of Losses------
Membership Dues------
Special Events----$1,301,122
Revenue In-Kind----$13,729
Expense Allocation
Fiscal Year201420132012
Program Expense------
Administration Expense------
Fundraising Expense$2,293,599$2,112,509$1,723,379
Payments to Affiliates------
Total Revenue/Total Expenses5.297.2318.72
Program Expense/Total Expenses0%0%0%
Fundraising Expense/Contributed Revenue20%15%5%
Assets and Liabilities
Fiscal Year201420132012
Total Assets------
Current Assets------
Long-Term Liabilities------
Current Liabilities------
Total Net Assets------
Short Term Solvency
Fiscal Year201420132012
Current Ratio: Current Assets/Current Liabilities------
Long Term Solvency
Fiscal Year201420132012
Long-Term Liabilities/Total Assets------
Capital Campaign
Currently in a Capital Campaign? Yes
Campaign Purpose The Research for Life Campaign will attract new resources for Massey's PEOPLE ($27M to recruit and retain leading physician-scientists, researchers, and clinical trials teams to spearhead Massey's research enterprise), PROGRAMS ($48M to increase funding for Massey's five core research programs, expand the number and geographic reach of our clinical trials effort, and increase new interdisciplinary research collaborations) and PLACES ($7M to provide our teams with technologically advanced research facilities on three floors of the new School of Medicine building, MCV Hall). Annual operational support is also including in the campaign total ($18M).
Goal $100,000,000.00
Dates July 2008 to June 2014
Amount Raised To Date $80,800,000.00
Capital Campaign Anticipated in Next 5 Years? Yes
State Charitable Solicitaions Permit
Solicitations Permit
Solicitations Permit ExemptionView
Foundation Comments
  • Financial information provided from year-end financial reports prepared by the Massey Cancer Center.
  • The Massey Cancer Center is a program of the Medical College of Virginia Foundation.
  • Massey Cancer Center does not have its own assets. All assets are held by the Medical College of Virginia Foundation.
  • Form 990s and audited financial statements for the Medical College of Virginia Foundation are available for your review under the Other Documents section.